Skip to content

Survey of vulvovaginal melanoma in Japan

Survey of vulvovaginal melanoma in Japan - JGOG1078S

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025968
Enrollment
200
Registered
2017-02-02
Start date
2016-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vulvovaginal melanoma

Interventions

None listed

Sponsors

Japanese Gynecologic Oncology Group (JGOG) Japanese Skin Cancer Society (JSCS)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Patients who received treatment for vulvar cancer during the 21-year period from January 1995 through December 2015, including those who initially received palliative therapy (2) Primary vulvovaginal melanoma, not including metastatic vulvovaginal melanoma

Exclusion criteria

Exclusion criteria: metastatic vulvovaginal melanoma

Design outcomes

Primary

MeasureTime frame
To conduct a survey of vulvovaginal melanoma in Japan to clarify patient characteristics and the current status of treatment regimens and thereby obtain useful information for planning future prospective clinical studies of vulvovaginal melanoma

Countries

Japan

Contacts

Public ContactShin Nishio

Kurume University School of Medicine Department of Obstetrics and Gynecology

shinshin@med.kurume-u.ac.jp0942-31-7573

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026